http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2157367-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_469203b27fe7c74e2b633023953cfe2f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
filingDate 1994-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a3943022175325bf3125d9ebfc25a64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c02575841570ae504c8cc0a4103a65c
publicationDate 2000-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2157367-C2
titleOfInvention Condensed pyrrole carboxanilides, new class of ligands of cerebral gaba-receptors
abstract FIELD: organic chemistry, pharmacology. SUBSTANCE: invention describes the novel derivatives of condensed pyrrole carboxamide of the general formula (I) and their pharmaceutically nontoxic salts where fragment (a) means groups of the formulas (b) and (c) given in the invention description and W means substituted or unsubstituted aryl; X means hydrogen atom, hydroxyl or lower alkyl; T means hydrogen, halogen atom, hydroxyl, amino-group or alkyl; R 3 means hydrogen atom or organic group; R 4 means hydrogen atom or substituted or unsubstituted organic substituent; R 5 and R 6 mean organic and inorganic substituents; n = 1, 2, 3 or 4. These compounds are highly active agonists, antagonists or reverse agonists of cerebral GABA-receptors or prodrugs of agonists, antagonists or reverse agonists of cerebral GABA-receptors. These compounds are useful also in diagnosis and treatment of patients with neurosis, insomnia, epilepsy, overdosing with drugs of benzodiazepine order and for memory improvement. EFFECT: new compounds indicated above, valuable pharmacological properties. 51 cl, 22 dwg, 1 tbl, 8 ex
priorityDate 1993-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467805299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465165816
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467295194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466338071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163567745
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466489925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466489926

Total number of triples: 69.